Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP270244.RAKRbJAugVn-3oBiC4oCLXqnrH3Q5Zmi-pzMH2YfWDy6A130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP270244.RAKRbJAugVn-3oBiC4oCLXqnrH3Q5Zmi-pzMH2YfWDy6A130_assertion type Assertion NP270244.RAKRbJAugVn-3oBiC4oCLXqnrH3Q5Zmi-pzMH2YfWDy6A130_head.
- NP270244.RAKRbJAugVn-3oBiC4oCLXqnrH3Q5Zmi-pzMH2YfWDy6A130_assertion description "[The expanded use of MTBDRplus DST resulted in a substantial increase in the proportion of new cases identified as MDR-TB; though time to MDR treatment was reduced, it was still over two months.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP270244.RAKRbJAugVn-3oBiC4oCLXqnrH3Q5Zmi-pzMH2YfWDy6A130_provenance.
- NP270244.RAKRbJAugVn-3oBiC4oCLXqnrH3Q5Zmi-pzMH2YfWDy6A130_assertion evidence source_evidence_literature NP270244.RAKRbJAugVn-3oBiC4oCLXqnrH3Q5Zmi-pzMH2YfWDy6A130_provenance.
- NP270244.RAKRbJAugVn-3oBiC4oCLXqnrH3Q5Zmi-pzMH2YfWDy6A130_assertion SIO_000772 23226229 NP270244.RAKRbJAugVn-3oBiC4oCLXqnrH3Q5Zmi-pzMH2YfWDy6A130_provenance.
- NP270244.RAKRbJAugVn-3oBiC4oCLXqnrH3Q5Zmi-pzMH2YfWDy6A130_assertion wasDerivedFrom befree-20150227 NP270244.RAKRbJAugVn-3oBiC4oCLXqnrH3Q5Zmi-pzMH2YfWDy6A130_provenance.
- NP270244.RAKRbJAugVn-3oBiC4oCLXqnrH3Q5Zmi-pzMH2YfWDy6A130_assertion wasGeneratedBy ECO_0000203 NP270244.RAKRbJAugVn-3oBiC4oCLXqnrH3Q5Zmi-pzMH2YfWDy6A130_provenance.